|
| |
Sirona Dental Systems, Inc. (NASD: SIRO)
provides a broad range
of advanced dental products in four primary areas: Dental CAD/CAM Systems;
Imaging Systems; Treatment Centers; and Instruments. The Company
distributes its products globally to dental practices, clinics and
laboratories through an international network of distributors. The Company's
revenue for the year ended September 30, 2007 was $659.9 million. The U.S.
market contributed 33% of revenue, or $215.9 million, and the rest of the world
contributing 67% of revenue, or $444.0 million.
The global dental market
encompasses the diagnosis, treatment and prevention of disease and ailments of
the teeth, gums and supporting bone. This market has enjoyed steady growth over
the past years, driven by a number of factors, including an increased desire for
aesthetics, a demographic shift towards an aging population coupled with a
desire to retain tooth structure later in life, growth in disposable income, a
desire for more convenience on the part of both dentists and patients, a shift
towards private pay, a greater need for dental preventative care and
technological innovation. The global dental market has been impacted by
technological developments that allow a dentist to increase productivity. This
is particularly important in markets where demand for dental services is
increasing and the number of dentists remains relatively fixed. In addition,
technological developments allow dentists to offer higher quality treatment to
patients.
The
stock's price gained 9.8% over the past 3 months (vs. the Industry's
49.7%); 53.4% over the past 6 months (vs. the Industry's 109.7 %); and
202.3% over the past 12 months (vs. the Industry's 163.5%). The Company
is classified as a small-cap growth company (with a market cap of $1.74B)
that is rated to outperform the market over the next six months with a Risk
Level of 3 (Average). The Company's
history dates back to 1882 and thru a number of acquisitions and
leveraged buy-out agreements, was acquired by Schick Technologies, Inc. on
2006 and was renamed
Sirona Dental Systems, Inc.
The Company's principal executive offices are located in
Long Island City, New York. The Company
has
2,388 employees.
Sector: Healthcare;
Industry:
Medical Equipment & Supplies;
Ticker: SIRO;
Exch:
NASD;
01/01/10
Closing Price:
$31.74
STOCK GRADE (ASG): 44.37 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 3
(Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
7.60% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
7.48% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
-5.79% |
|
. . . |
EPS: |
80.88% |
|
. . . |
Price: |
202.29% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
32.96 |
|
. . . |
Earnings/Share: |
0.96 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 01/01/2010: |
$31.74 |
COMMENT: The stock's pick price (of $31.74) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $32.04)
and higher than the 50-day EMA (of $30.83) by -0.94% and 2.95% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
01/01/2010: |
$32.04 |
| Price
/ Share (50-day EMA) |
. . . |
01/01/2010: |
$30.83 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Informatica Corp. (NASD: INFA) is a provider of enterprise data integration and data quality software
and services that enable organizations to gain greater business value from their
information assets. The Company's open, platform-neutral software
accesses data of virtually all types and makes such data accessible and usable
to the people and processes that need it. The Company software handles a
wide variety of complex enterprise-wide data integration initiatives, including
data migration, data consolidation, data synchronization, data warehousing,
establishment of data hubs, data services, cross-enterprise data exchange, and
data quality. The Company's
products are designed to enable customers to gain greater business value by
integrating their information assets and simplify their IT infrastructure by
providing a unified platform for all enterprise data integration initiatives.
For the business customer, the Company's products provide
near-universal access to enterprise data—structured data in databases as well as
unstructured and semi-structured enterprise data locked in documents and
industry-specific data formats.
The Company's
products feature the unique ability to access batch, federated, and changed data
from mainframe, legacy, and relational systems and deliver that data at the
frequency demanded by the business. The Company have more than 2,950
customers representing a worldwide variety of industries, ranging from energy
and utilities, financial services, government and public sector, healthcare,
high technology, insurance, manufacturing, retail, services, telecommunications,
and transportation.
The Company
market and sell its software and services through global direct sales operations
in North and Latin America (including Brazil, Canada, Mexico and the United
States), Europe, Middle East, and Africa (including Austria, Belgium, France,
Germany, Ireland, Israel, the Netherlands, Switzerland, United Arab Emirates,
and the United Kingdom), and Asia-Pacific (including Australia, China, India,
Japan, the Philippines, Singapore, South Korea, and Taiwan).
The
stock's price gained 14.3% over the past 3 months (vs. the Industry's
40.9%); 53.3% over the past 6 months (vs. the Industry's 169.3 %); and
86.1% over the past 12 months (vs. the Industry's 289.9%). The Company
is classified as a mid-cap growth company (with a market cap of $2.31B)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The Company was founded in 1993 and its principal executive offices are located
Redwood City, California. The Company
has
1,611 employees.
Sector: Technology;
Industry:
Software & Programming;
Ticker: INFA;
Exch:
NASD;
01/08/10
Closing Price:
$ 25.83
STOCK GRADE (ASG): 50.49 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
15.00% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
12.47% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
16.47% |
|
. . . |
EPS: |
2.20% |
|
. . . |
Price: |
86.10% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
41.80 |
|
. . . |
Earnings/Share: |
0.62 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 01/08/2010: |
$25.83 |
COMMENT: The stock's pick price (of $25.83) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $25.91)
and higher than the 50-day EMA (of $24.13) by -0.30% and 7.04% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
01/08/2010: |
$25.91 |
| Price
/ Share (50-day EMA) |
. . . |
01/08/2010: |
$24.13 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Tech Data Corp. (NASD: TECD)
is a distributor of
information technology (“IT”) products, logistics management and other
value-added services worldwide. The Company sell more than 100,000
products from the world’s leading peripheral, system and networking
manufacturers and software publishers. These products are typically purchased
directly from the manufacturer or software publisher on a non-exclusive basis.
The Company offer a variety of products from manufacturers and publishers
such as Acer, Adobe, American Power, Apple, Autodesk, Canon, Cisco Systems,
Epson, Fujitsu-Siemens, Hewlett-Packard, IBM, Intel, Kingston, Lexmark, Lenovo,
Logitech, Microsoft, Nortel Networks, Samsung, Seagate, Sony, Symantec, Toshiba,
Western Digital and Xerox.
During fiscal 2008, sales within the Company's consolidated product
categories approximated the following: Peripherals - 40 %; Systems - 30 %;
Networking - 15 %; Software - 15 %. The Company generated approximately
28% of its consolidated net sales in fiscal 2008, 2007 and 2006 from products
purchased from Hewlett Packard.
The large number of resellers makes it cost efficient for vendors to rely on
wholesale distributors to serve their diverse customer base. As a result,
vendors frequently rely on wholesale distributors, such as Tech Data, who
can leverage purchasing costs across multiple vendors to satisfy a significant
portion of the vendors' product procurement, logistics, financing, marketing and
technical support needs. Through collaborative supply chain management
initiatives and by leveraging the Company's infrastructure and logistics
expertise, vendors benefit from a cost-effective alternative to selling directly
to resellers. The Company's ability to provide a “virtual
warehouse” of products for resellers means the latter no longer need to hold
inventory, which reduces their costs and risks associated with handling
products.
The
stock's price gained 9.7% over the past 3 months (vs. the Industry's
5.8%); 35.6% over the past 6 months (vs. the Industry's 20.8 %); and
132.4% over the past 12 months (vs. the Industry's 176.9%). The Company
is classified as a mid-cap value company (with a market cap of $1.85B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1974 and its principal executive offices are located
Clearwater, Florida. The Company
has
8,000 employees.
Sector: Technology;
Industry:
Computer Hardware; Ticker: TECD;
Exch:
NASD;
01/15/10
Closing Price:
$45.30
STOCK GRADE (ASG): 45.90 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
7.60% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
7.48% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
2.81% |
|
. . . |
EPS: |
22.59% |
|
. . . |
Price: |
132.43% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
35.05 |
|
. . . |
Earnings/Share: |
0.96 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 01/15/2010: |
$45.30 |
COMMENT: The stock's pick price (of $45.30) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $46.51)
and higher than the 50-day EMA (of $44.83) by -2.60% and 1.04% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
01/15/2010: |
$46.51 |
| Price
/ Share (50-day EMA) |
. . . |
01/15/2010: |
$44.83 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Odyssey Healthcare Inc. (NASD: ODSY)
is a provider of hospice care in the United States. Hospice services are
designed to provide a wide range of care and services to terminally ill patients
and their families. The Company assign each of its hospice patients to an
interdisciplinary team, which assesses the clinical, psychosocial and spiritual
needs of the patient and his or her family, develops a plan of care and
delivers, monitors and coordinates that plan of care with the goal of providing
appropriate care for the patient and his or her family. This interdisciplinary
team approach offers significant benefits to hospice patients, their families
and payors, including: the provision of coordinated care and treatment; clear
accountability for clinical outcomes and cost of services; and the potential
reduction of stress and dysfunction of patients and their families.
Substantially all of The Company's net patient service revenue is
attributable to payments received from the Medicare and Medicaid programs. 97.1%
and 96.9% of the Company's net patient service revenue for the years
ended December 31, 2006 and 2007, respectively, were attributable to Medicare
and Medicaid payments. At year-end 2007 the Company's provided care from 72
Medicare-certified hospice programs in 29 states. On March 6, 2008 the Company
acquired VistaCare, Inc (“VistaCare”). After the completion of the VistaCare
acquisition the Company now serve approximately 12,000 patients and their
families each day through approximately 110 Medicare-certified hospice locations
in 30 states.
The
stock's price gained 24.2% over the past 3 months (vs. the Industry's
-14.5%); 40.9% over the past 6 months (vs. the Industry's 161.5 %); and
71.0% over the past 12 months (vs. the Industry's 364.8%). The Company
is classified as a small-cap value company (with a market cap of $509.87M)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1995 and its principal executive offices are located
Dallas, Texas. The Company
has
6,013 employees.
Sector: Healthcare; Industry:
Healthcare Facilities; Ticker: ODSY;
Exch:
NASD;
01/22/10
Closing Price:
$15.39
STOCK GRADE (ASG): 47.43 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
16.43% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
5.02% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
54.70% |
|
. . . |
EPS: |
23.00% |
|
. . . |
Price: |
71.00% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
14.93 |
|
. . . |
Earnings/Share: |
1.03 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 01/22/2010: |
$15.39 |
COMMENT: The stock's pick price (of $15.39) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $16.05)
and higher than the 50-day EMA (of $15.35) by -4.11% and 0.27% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
01/22/2010: |
$16.05 |
| Price
/ Share (50-day EMA) |
. . . |
01/22/2010: |
$15.35 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
MicroStrategy Inc. (NASD: MSTR)
is a worldwide provider of business intelligence software. Business intelligence software offers decision-makers the
opportunity to ask and answer questions about data that has been captured but
not yet fully exploited. The Company's software platform, MicroStrategy
8, enables users to query and analyze the most detailed, transaction-level
databases, turning data into business intelligence and delivering boardroom
quality reports and alerts about the users’ business processes. The Company's
web-based architecture provides reporting, security, performance and standards
that are critical for web deployment. By integrating information from across the
enterprise, solutions built on the MicroStrategy platform are designed to give
analysts, managers and executives the critical insight they need to make better
business and management decisions and to optimize their operations.
MicroStrategy 8 is an integrated, business intelligence platform designed to
enable organizations to consolidate business intelligence applications onto a
single platform for reporting, analysis and monitoring of real-time business
information. The platform provides reliable and maintainable solutions with a
low total cost of ownership and can be used in departmental, enterprise or
extranet deployments.
The
stock's price gained 30.0% over the past 3 months (vs. the Industry's
17.9%); 62.9% over the past 6 months (vs. the Industry's 84.0 %); and
138.8% over the past 12 months (vs. the Industry's 273.1%). The Company
is classified as a small-cap growth company (with a market cap of $1.14B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1989 and its principal executive offices are located
McLean, Virginia. The Company
has
1,915 employees.
Sector: Technology; Industry:
Software & Programming; Ticker: MSTR;
Exch:
NASD;
01/29/10
Closing Price:
$93.72
STOCK GRADE (ASG): 47.43 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
33.95% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
18.69% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
7.46% |
|
. . . |
EPS: |
-26.30% |
|
. . . |
Price: |
158.76% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
17.13 |
|
. . . |
Earnings/Share: |
5.60 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 01/29/2010: |
$93.72 |
COMMENT: The stock's pick price (of $93.72) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $97.39)
and higher than the 50-day EMA (of $92.16) by -1.54% and 4.05% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
01/29/2010: |
$97.39 |
| Price
/ Share (50-day EMA) |
. . . |
01/29/2010: |
$92.16 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Comp. de Bebidas Das Americas (AMBEV) (NASD: ABV)
produce, distribute and sell beer, carbonated soft drinks and other
non-alcoholic and non-carbonated products in 14 countries across the Americas.
The Company is PepsiCo’s largest bottler outside the United States
and is the largest brewer in Latin America in terms of sales volume. The
Company conduct its operations through the following three business units:
Brazil, Hispanic Latin America (“HILA”), and North America. The Brazil Unit
includes three divisions: (i) beer sales (“Beer Brazil”); (ii) carbonated soft
drinks and non-alcoholic non-carbonated sales (“CSD & NANC”); and (iii) sales of
malt and by-products to third parties (“Other Products”). The HILA Unit
includes: (i) Quinsa’s operations (Argentina, Bolivia, Paraguay, Uruguay and
Chile); and (ii) the operations in the Dominican Republic, Ecuador, Guatemala
(which also serves Nicaragua and El Salvador), Peru and Venezuela. The North
America Unit includes domestic sales in Canada and beer exports to the
United States.
In 2007, Brazil was the world’s fourth largest beer market in terms of volume,
reaching 104.38 million hectoliters. As of March 2008, according to Nielsen, the
Company had a 67.0% market share in terms of beer sales volumes, mainly
through its three major brands, Skol , Brahma and Antarctica . The CSD & NANC
markets in Brazil are comprised of many different segments, including CSD,
bottled water, isotonics and iced teas. The CSD segment represents more than 90%
of the profits of the Company's CSD & NANC business unit.
The
stock's price gained -6.1% over the past 3 months (vs. the Industry's
-22.1%); 22.7% over the past 6 months (vs. the Industry's 61.7 %); and
109.9% over the past 12 months (vs. the Industry's 344.9%). The Company
is classified as a large-cap growth company (with a market cap of $55.79B)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The Company is the successor company to two of the
oldest brewers in Brazil, the oldest brewer of the two being founded in 1885.
The Company's principal executive offices are located
Sao Paulo Brazel. The Company
has
39,301 employees.
Sector:
Consumer/Non-Cyclical;
Industry:
Beverages-Alcoholic;
Ticker: ABV;
Exch:
NASD;
02/05/10
Closing Price:
$90.50
STOCK GRADE (ASG): 51.10 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 1
(Very Low)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
20.54% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
16.70% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
5.79% |
|
. . . |
EPS: |
3.99% |
|
. . . |
Price: |
109.88% |
|
. . . |
Dividend: |
69.16% |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
27.36 |
|
. . . |
Earnings/Share: |
3.31 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 02/05/2010: |
$90.50 |
COMMENT: The stock's pick price (of $90.50) is under the 13-day EMA and
the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $96.15)
and the 50-day EMA (of $97.69) by -5.88% and -7.36% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
02/05/2010: |
$96.15 |
| Price
/ Share (50-day EMA) |
. . . |
02/05/2010: |
$97.69 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Watson Pharmaceuticals Inc.
(NYSE: WPI) develop, manufacture and sell brand and generic (off-patent)
pharmaceutical products. As of December 31, 2007, the Company marketed
150 generic pharmaceutical product families and 27 brand pharmaceutical product
families. Prescription pharmaceutical products in the U.S. generally are
marketed as either generic or brand pharmaceuticals. Generic pharmaceutical
products are bioequivalents of their respective brand products and provide a
cost-efficient alternative to brand products. Brand pharmaceutical products are
marketed under brand names through programs that are designed to generate
physician and consumer loyalty. Through our distribution operation, we
distribute pharmaceutical products, primarily generics, which have been
commercialized by us and others, to independent and chain pharmacies and
physicians’ offices.
The Company's
operations are based predominantly in the United States (U.S.) and India, with
its key commercial market being the U.S. The Company's
portfolio of generic products includes products developed internally,
products licensed from third parties and products that are distributed for
third parties.
During 2007, the Company expanded its generic product
line with the launch of 16 generic products. Key launches in 2007 included
bupropion hydrochloride tablets, an anti-depressant; transdermal fentanyl, an
analgesic; albuterol sulfate inhalation solution, a bronchodilator; and Tilia tm
Fe, an oral contraceptive. Net revenues in the Company's
generic segment accounted for $1.5 billion or approximately 60% of total net
revenues in 2007.
The
stock's price gained 5.9% over the past 3 months (vs. the Industry's
23.2%); 10.8% over the past 6 months (vs. the Industry's 106.7 %); and
29.4% over the past 12 months (vs. the Industry's 215.0%). The Company
is classified as a mid-cap growth company (with a market cap of $4.04B)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The Company was founded in 1983.
The Company's principal
executive offices are located Corona, California. The Company
has
5,070 employees.
Sector: Healthcare;
Industry:
Biotechnology & Drugs;
Ticker: WPI;
Exch:
NYSE;
02/12/10
Closing Price:
$38.08
STOCK GRADE (ASG): 45.14 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 1
(Very Low)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
10.16% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
8.35% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
1.56% |
|
. . . |
EPS: |
64.56% |
|
. . . |
Price: |
29.44% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
19.63 |
|
. . . |
Earnings/Share: |
1.94 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 02/12/2010: |
$38.08 |
COMMENT: The stock's pick price (of $38.08) is under the 13-day EMA and
the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $38.45)
and the 50-day EMA (of $38.52) by -0.97% and -1.41% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
02/12/2010: |
$38.45 |
| Price
/ Share (50-day EMA) |
. . . |
02/12/2010: |
$38.52 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Bruker Corp. (NASD: BRKR) design, manufacture, service and
market analytical and life science systems and associated products to address
the needs of companies in life science research,
pharmaceutical, biotechnology and molecular diagnostics research, as well as in
materials and chemical analysis in various industries and government
applications. The Company currently has three operating segments: Bruker
AXS, Bruker Daltonics and Bruker Optics. Bruker AXS' systems are advanced
instruments that use extremely short wavelengths of energy to determine the
characteristics of matter and the three-dimensional structure of molecules. The Company's
products provide its customers with the ability to determine the
three-dimensional structure of specific molecules, such as proteins, and to
characterize and determine the composition of materials down to the dimensions
used in nanotechnology. The Company's customers include biotechnology and pharmaceutical
companies, nanotechnology companies, semiconductor companies, raw material
manufacturers, chemical companies, academic institutions and other businesses
involved in materials analysis.
Bruker Daltonics' mass spectrometers are sophisticated devices that measure the
mass or weight of a molecule and can provide accurate information on the
identity, quantity and primary structure of molecules. The Company's
customers include pharmaceutical companies, biotechnology companies, proteomics
companies, molecular diagnostics companies, academic institutions and government
agencies.
Bruker Optics manufactures and distributes research, analytical and process
analysis instruments based on infrared (IR), near-infrared (NIR), FT-Raman,
Dispersive Raman and time-domain magnetic resonance (TD-NMR) spectroscopy. These
products are utilized in industry, government and academia for a wide range of
applications and solutions for life science, pharmaceutical analysis, food and
agricultural analysis in research and development, quality control and process
analysis applications.
The
stock's price gained 9.4% over the past 3 months (vs. the Industry's
16.0%); 26.4% over the past 6 months (vs. the Industry's 37.4 %); and
201.9% over the past 12 months (vs. the Industry's 233.1%). The Company
is classified as a mid-cap growth company (with a market cap of $2.05B)
that is rated to outperform the market over the next six months with a Risk
Level of 3 (Average). The Company was founded in 1991. The Company's principal
executive offices are located Billerica, California. The Company
has
3,8 50 employees.
Sector: Technology;
Industry: Scientific & Technical Instruments;
Ticker: BRKR;
Exch:
NASD;
02/26/10
Closing Price:
$12.50
STOCK GRADE (ASG): 44.37 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 3
(Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
19.16% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
6.01% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
0.67% |
|
. . . |
EPS: |
25.65% |
|
. . . |
Price: |
201.93% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
32.30 |
|
. . . |
Earnings/Share: |
0.39 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 02/26/2010: |
$12.50 |
COMMENT: The stock's pick price (of $12.50) is under the 13-day EMA and
the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $13.04)
and the 50-day EMA (of $12.65) by -4.11% and -1.22% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
02/26/2010: |
$13.04 |
| Price
/ Share (50-day EMA) |
. . . |
02/26/2010: |
$12.65 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
|
February
2010 Stock Picks |
|
Stock Name |
SYM |
Exch. |
Sector |
Industry |
Date Picked |
Pick Price
(per share) |
ASG |
|
The J.M. Smucker Co. |
SJM |
NYSE |
Consumer/Non-Cyclical
|
Food Procesing |
03/05/10 |
$59.66 |
55.08
(VERY GOOD) |
|
Intuitive Surgical, Inc. |
ISRG |
NASD |
Healthcare
|
Medical Equipment &
Supplies |
03/19/10 |
$349.18 |
46.67
(GOOD) |
|
Coca-Cola FEMSA |
KOF |
NYSE |
Consumer/Non-Cyclical
|
Beverages/Non-Alcoholic |
03/25/10 |
$64.83 |
52.79
(VERY GOOD) |
 The J.M. Smucker Co. (NYSE: SJM)
manufactures and markets branded food products on a worldwide basis. Majority of
the Company’s sales are in the United States. The Company’s
operations outside the United States are principally in Canada although products
are exported to other countries as well. Sales outside the United States
represent approximately 15 percent of total consolidated Company sales
for fiscal 2007. The principal products of the Company are peanut butter,
shortening and oils, flour and baking ingredients, fruit spreads, baking mixes
and ready-to-spread frostings, fruit and vegetable juices, beverages, dessert
toppings, syrups, frozen sandwiches, pickles and condiments, potato side dishes
and canned milk.
The Company’s U.S. retail market segment, comprising over 70 percent of
the Company’s net sales, includes the consumer and consumer oils and
baking businesses and represents a large portion of the strategic focus area for
the Company – the sale of branded food products with leadership positions
to consumers through retail outlets in North America. The special markets
segment represents the aggregation of the foodservice, beverage, Canada, and
international businesses. In the U.S. retail market segment, the Company’s
products are primarily sold through brokers to food retailers, food wholesalers,
club stores, mass merchandisers, discount stores, and military commissaries. In
the special markets segment, theCompany’s products are distributed
domestically and in foreign countries through retail channels, foodservice
distributors and operators (i.e., restaurants, schools and universities,
healthcare operators), other food manufacturers, health and natural foods stores
and distributors.
The
stock's price gained -0.10% over the past 3 months (vs. the Industry's
6.4%); 15.3% over the past 6 months (vs. the Industry's 60.6 %); and
72.7% over the past 12 months (vs. the Industry's 231.3%). The Company
is classified as a mid-cap growth company (with a market cap of $7.10B)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The Company was founded in 1897. The Company's principal
executive offices are located Orrville Ohio. The Company
has
4,700 employees.
Sector:
Consumer/Non-Cyclical; Industry: Food Processing;
Ticker: SJM;
Exch:
NYSE;
03/05/10
Closing Price:
$59.66
STOCK GRADE (ASG): 55.08 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 1
(Very Low)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
9.21% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
10.16% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
48.84% |
|
. . . |
EPS: |
3.81% |
|
. . . |
Price: |
60.34% |
|
. . . |
Dividend: |
7.38% |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
15.09 |
|
. . . |
Earnings/Share: |
3.95 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 03/05/2010: |
$59.66 |
COMMENT: The stock's pick price (of $59.66) is under the 13-day EMA and
50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $59.80)
and the 50-day EMA (of $59.91) by -0.24% and -0.42% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
03/05/2010: |
$59.80 |
| Price
/ Share (50-day EMA) |
. . . |
03/05/2010: |
$59.91 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Intuitive Surgical, Inc. (NASD: ISRG)
design, manufacture and market products
that are designed to make a broad range of open surgical and minimally invasive
surgical (MIS) procedures suitable for da Vinci surgery. The da Vinci Surgical
System is designed to enable surgeons to improve surgical outcomes while
providing patients with the benefits of MIS. With the da Vinci System, surgeons
operate while seated comfortably at a console viewing a high resolution, 3-D
image of the surgical field. The immersive visualization connects the surgeon to
the surgical field and the instruments. While seated at the console, the surgeon
manipulates instrument controls in a natural manner, just as he or she has been
trained to do in open surgery.
In March 1997, surgeons using an early prototype of the Company's
technology successfully performed the first da Vinci surgery on humans. In the
second quarter of 1999,
the Company
began selling da Vinci products and services outside the United States. In July
2000,
the Company
obtained clearance from the U.S. Food and Drug Administration (FDA) to market
its products in the United States for use in General laparoscopic procedures. As
of December 31, 2007,
the Company
had sold over 800 of the da Vinci Surgical Systems, and surgeons using the
Company's technology had successfully completed more than one hundred and fifty
thousand surgical procedures of various types in major hospitals throughout
North America, South America, Europe, the Middle East, Australia and Asia.
During the twelve months ended December 31, 2007, surgeons using
the Company's
products performed over 55,000 prostatectomy procedures and over 13,000
hysterectomy procedures worldwide.
The
stock's price gained 20.8% over the past 3 months (vs. the Industry's
30.1%); 40.8% over the past 6 months (vs. the Industry's 68.0 %); and
259.3% over the past 12 months (vs. the Industry's 256.4%). The Company
is classified as a large-cap growth company (with a market cap of $13.44B)
that is rated to outperform the market over the next six months with a Risk
Level of 3 (Average). The Company was founded in 1995. The Company's principal
executive offices are located Sunnyvale, California. The Company
has
1,263 employees.
Sector: Healthace;
Industry: Medical Equipment & Supplies;
Ticker: ISRG;
Exch:
NASD;
03/19/10
Closing Price:
$349.18
STOCK GRADE (ASG): 46.67 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 3
(Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
16.59% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
22.11% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
20.26% |
|
. . . |
EPS: |
15.99% |
|
. . . |
Price: |
247.64% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
58.85 |
|
. . . |
Earnings/Share: |
5.93 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 03/19/2010: |
$349.18 |
COMMENT: The stock's pick price (of $349.18) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $353.80)
and higher than the 50-day EMA (of $336.57) by -1.39% and 3.75% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
03/19/2010: |
$353.80 |
| Price
/ Share (50-day EMA) |
. . . |
03/19/2010: |
$336.57 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Coca-Cola FEMSA SAB de C.V. (NYSE:
KOF)
produce, market and
distribute Coca-Cola trademark beverages, proprietary brands and brands licensed
from third parties. The Coca-Cola trademark beverages include colas, flavored
soft drinks, water and beverages in other categories such as juice drinks and
isotonics. The Company is
the largest bottler of Coca-Cola
trademark beverages in Latin America in terms of total sales volume in 2006,
with operations in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia,
Venezuela, Argentina and Brazil.
The Company's
most important brand is Coca-Cola and its line extensions, Coca-Cola light ,
Coca-Cola light caffeine free and Coca-Cola light with lime , which together
accounted for 62.5% of total sales volume in 2006. Ciel (including jug
presentations), Fanta, Sprite, Lift and Fresca , are the next largest brands in
consecutive order, accounted for 10.5%, 6.1%, 3.0%, 1.9% and 1.7%, respectively,
of total sales volume in 2006.
The Company
produce, market and distribute Coca-Cola trademark beverages in each of its
business territories in containers authorized by The Coca-Cola Company, which
consist of a variety of returnable and non-returnable presentations in the form
of glass bottles, cans and plastic bottles made of polyethylene terephtalate.
The
stock's price gained -3.1% over the past 3 months (vs. the Industry's
3.1%); 36.1% over the past 6 months (vs. the Industry's 37.3 %); and
79.5% over the past 12 months (vs. the Industry's 168.7%). The Company
is classified as a mid-cap growth company (with a market cap of $11.97B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than average). The Company was founded in 1991. The
Company's principal
executive offices are located Mexico City, Mexico. The Company
has
65,021 employees.
Sector: Concumer/Non-Cyclical; Industry: Beverages/Non-Alcoholic;
Ticker: KOF;
Exch:
NYSE;
03/26/10
Closing Price:
$64.83
STOCK GRADE (ASG): 52.79 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
13.96% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
8.29% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
19.82% |
|
. . . |
EPS: |
-17.65% |
|
. . . |
Price: |
79.53% |
|
. . . |
Dividend: |
42.15% |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
17.63 |
|
. . . |
Earnings/Share: |
3.68 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 03/26/2010: |
$64.83 |
COMMENT: The stock's pick price (of $64.83) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $64.90)
and higher than the 50-day EMA (of $63.44) by -0.13% and 2.19% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
03/26/2010: |
$64.90 |
| Price
/ Share (50-day EMA) |
. . . |
03/26/2010: |
$63.44 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Amedisys Inc. (NASD: AMED)
deliver a wide range of services in the homes of individuals who may be
recovering from surgery, have a chronic disability or terminal illness or need
assistance with the essential activities of daily living. The services the
Company provide include skilled nursing and home health aide services;
physical, occupational and speech therapy; and medically oriented social work to
eligible individuals who require ongoing care that cannot be provided
effectively by family and friends. In addition, the Company have
developed and offer clinically focused programs for high cost chronic conditions
and various diseases, such as diabetes, coronary artery disease, congestive
heart failure, complex wound care, chronic obstructive pulmonary disease (“COPD”),
geriatric surgical recovery, behavioral health, and stroke recovery, as well as
various rehabilitative programs. In each case, the Company focus on
improving the functional ability of its geriatric population and enhancing
patient self-management through compliance tracking and behavioral modification.
Through the Company's
hospice agencies, palliative care and comfort is provided to terminally ill
patients and their families. As of December 31, 2007, the Company
owned and operated 325 Medicare-certified home health agencies, 29
Medicare-certified hospice agencies and managed the operations of four
Medicare-certified home health and two Medicare-certified hospice agencies in 30
states within the United States. The Company's
typical home health patient is Medicare eligible, 80 to 84 years old and takes
approximately eight different medications on a daily basis. From their home
health patients, the Company
typically receive a 60-day episodic-based payment from Medicare that averages
$2,666 for each episode of care that was provided.
The
stock's price gained 17.3% over the past 3 months (vs. the Industry's
31.4%); 33.3% over the past 6 months (vs. the Industry's 72.1 %); and
108.0% over the past 12 months (vs. the Industry's 183.3%). The Company
is classified as a mid-cap value company (with a market cap of $1.61B)
that is rated to outperform the market over the next six months with a Risk
Level of 3 (Average). The Company was founded in 1982. The Company's principal
executive offices are located Baton Rouge, Louisinia. The Company
has
6,700 employees.
Sector: Healthcare; Industry:Healthcare
Facilities;
Ticker: AMED;
Exch:
NASD;
04/02/10
Closing Price:
$56.99
STOCK GRADE (ASG): 47.43 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 3
(Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
20.95% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
8.98% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
27.46% |
|
. . . |
EPS: |
51.87% |
|
. . . |
Price: |
107.99% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
11.65 |
|
. . . |
Earnings/Share: |
4.89 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 04/02/2010: |
$56.99 |
COMMENT: The stock's pick price (of $64.83) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $64.90)
and higher than the 50-day EMA (of $63.44) by -0.13% and 2.19% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
04/02/2010: |
$57.67 |
| Price
/ Share (50-day EMA) |
. . . |
04/02/2010: |
$56.75 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
ResMed Inc. (NYSE: RMD)
is a developer, manufacturer and distributor of medical equipment for treating,
diagnosing, and managing sleep-disordered breathing and other respiratory
disorders. Sleep-disordered breathing ("SDB"), includes obstructive sleep apnea
(" OSA"), and other respiratory disorders that occur during sleep. The
Company was formed to commercialize a treatment, called nasal Continuous
Positive Airway Pressure ("CPAP") for OSA. CPAP was the first successful
noninvasive treatment for OSA. CPAP systems deliver pressurized air, typically
through a nasal mask, to prevent collapse of the upper airway during sleep.
The Company
have also developed a number of innovative products for SDB and other
respiratory disorders including airflow generators, diagnostic products, mask
systems, headgear and other accessories. The Company's market focus of
its operations is in the sleep-disordered breathing sector of the respiratory
medicine industry.
During CPAP treatment, a patient sleeps with a nasal interface connected to a
small portable airflow generator that delivers room air at a positive pressure.
The patient breathes in air from the flow generator and breathes out through an
exhaust port in the interface. Continuous air pressure applied in this manner
acts as a pneumatic splint to keep the upper airway open and unobstructed.
Scientists estimate that one in five adults have some form of obstructive sleep
apnea. In the United States alone, this represents approximately 43 million
people. It is estimated that less than 10% of those with OSA have been diagnosed
or treated. Many healthcare professionals are often unable to diagnose OSA
because they are unaware that such non-specific symptoms as excessive daytime
sleepiness, snoring, hypertension and irritability are characteristic of OSA.
The
stock's price gained 17.9% over the past 3 months (vs. the Industry's
17.0%); 34.6% over the past 6 months (vs. the Industry's 80.7 %); and
72.7% over the past 12 months (vs. the Industry's 212.4%). The Company
is classified as a mid-cap growth company (with a market cap of $462.77M)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The
Company was founded in 1989. The
Company's principal
executive offices are located San Diego, California. The Company
has
2,900 employees.
Sector: Healthcare;
Industry: Medical Equipment & Supplies;
Ticker: RMD;
Exch:
NYSE;
04/09/10
Closing Price:
$61.58
STOCK GRADE (ASG): 51.26 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 1
(Very Low)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
15.55% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
17.23% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
10.22% |
|
. . . |
EPS: |
35.52% |
|
. . . |
Price: |
72.69% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
27.43 |
|
. . . |
Earnings/Share: |
0.22 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 04/09/2010: |
$61.58 |
COMMENT: The stock's pick price (of $61.58) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $62.49)
and higher than the 50-day EMA (of $59.41) by -1.45% and 3.65% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
04/09/2010: |
$62.49 |
| Price
/ Share (50-day EMA) |
. . . |
04/09/2010: |
$59.41 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Sara Lee Corp. (NYSE: SLE)
is a manufacturer and marketer of a variety of brand-named meat, baked and
personal-and-household care products for consumers throughout the world. The
Company's retail meats are sold in the U.S. and Mexico. Products in this
segment include hot dogs and corn dogs, breakfast sausages and sandwiches,
smoked and dinner sausages, premium deli and luncheon meats, bacon, and cooked
and dry hams.
The Company's
retail bakery's products are sold to consumers in North America. Products in
this segment include bread, buns, bagels, rolls, muffins, specialty bread,
frozen pies, cakes, cheesecakes and other desserts.
The Company's
Foodservice segment sells a variety of meat, bakery and beverage products
to foodservice customers in North America.
The Company's
International Beverage segment sells coffee and tea products in Europe, Brazil,
Australia and Asia.
The Company's
International Bakery sgment sells a variety of bakery and dough products to
retail and foodservice customers in Europe and Australia.
The Company's
Household and Body Care segment sells products in four primary categories:
body care, air care, shoe care and insecticides. Body care consists of soaps,
shampoos, bath and shower products, deodorants, shaving creams and toothpastes,
which are sold primarily in Europe.
The
stock's price gained 15.4% over the past 3 months (vs. the Industry's
4.3%); 25.8% over the past 6 months (vs. the Industry's 26.2 %); and
62.3% over the past 12 months (vs. the Industry's 174.4%). The Company
is classified as a large-cap value company (with a market cap of $9.73B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The
Company was founded in 1939. The Company's principal
executive offices are located Downer's Grove Illinois. The Company
has
41,000 employees.
Sector:
Consumer/Non-Cyclical; Industry: Food
Processing;
Ticker: SLE;
Exch:
NYSE;
04/16/10
Closing Price:
$13.96
STOCK GRADE (ASG): 47.43 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
28.06% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
6.36% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
-2.51% |
|
. . . |
EPS: |
1,003.00% |
|
. . . |
Price: |
62.33% |
|
. . . |
Dividend: |
4.76% |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
12.13 |
|
. . . |
Earnings/Share: |
1.15 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 04/16/2010: |
$13.96 |
COMMENT: The stock's pick price (of $13.96) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $14.06)
and higher than the 50-day EMA (of $13.66) by -0.70% and 2.20% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
04/16/2010: |
$14.06 |
| Price
/ Share (50-day EMA) |
. . . |
04/16/2010: |
$13.66 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Chemed Corp. (NYSE: CHE)
operates two business
segments; VITAS Healthcare Corporation and Roto-Rooter. VITAS focuses on
non-curative hospice care that helps make terminally ill patients' final days as
comfortable and pain-free as possible. Through its teams of nurses, home health
aides, doctors, social workers, clergy, and volunteers, VITAS provides direct
medical services to patients, as well as spiritual and emotional counseling to
both patients and their families. At
year-end 2005, VITAS cared for more than 10,400 patients daily in 15 states,
primarily in the patients' own homes, but also in VITAS' inpatient units located
in hospitals, nursing homes, and assisted-living/residential-care facilities for
the elderly.
Roto-Rooter is engaged in all aspects of sewer, drain, pipe cleaning, HVAC
services and plumbing repair for residential and commercial customers. Roto-Rooter operates through more than 110 company-owned branches and
independent contractors and approximately 500 franchisees. The total Roto-Rooter
system offers services to more than 91% of the U.S. population and approximately
43% of the Canadian population. Roto-Rooter also has licensed master franchisees
in China, including Hong Kong; the republics of Indonesia and Singapore; Japan;
Mexico; the Philippines; and the United Kingdom.
The
stock's price gained 15.1% over the past 3 months (vs. the Industry's
39.7%); 18.8% over the past 6 months (vs. the Industry's 72.7 %); and
37.4% over the past 12 months (vs. the Industry's 195.3%). The Company
is classified as a mid-cap value company (with a market cap of $1.24B)
that is rated to outperform the market over the next six months with a Risk
Level of 1 (Very Low). The
Company was founded in 1971. The Company's principal
executive offices are located Cincinnati, Ohio Illinois. The
Company
has
12,308 employees.
Sector:
Healthcare;
Industry: Healthcare Facilities;
Ticker: CHE;
Exch:
NYSE;
04/23/10
Closing Price:
$55.03
STOCK GRADE (ASG): 54.32 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 1
(Very Low)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
16.18% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
6.13% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
3.59% |
|
. . . |
EPS: |
11.30% |
|
. . . |
Price: |
37.71% |
|
. . . |
Dividend: |
50.00% |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
17.03 |
|
. . . |
Earnings/Share: |
3.23 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 04/23/2010: |
$55.03 |
COMMENT: The stock's pick price (of $55.03) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $55.61)
and higher than the 50-day EMA (of $54.17) by -0.70% and 2.20% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
04/23/2010: |
$55.61 |
| Price
/ Share (50-day EMA) |
. . . |
04/23/2010: |
$54.17 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
 Atheros Communications Inc. (NASD: ATHR) is
a developer of highly integrated
semiconductor systems for communication integrated circuit products. The
Company's
products are used by a broad base of customers, including makers of personal
computers, networking equipment and consumer electronics devices. The
Company's product
portfolio includes Wireless Local Area Network (WLAN), mobile WLAN, Ethernet,
Bluetooth, Global Positioning System (GPS) and Personal Access Systems (PAS)
technologies. The
Company currently market
its products to makers of personal computers, networking equipment and consumer
electronic devices for use in both wireless and wired communications solutions.
The availability and growth of communication IC technologies over the last
decade have both encouraged and enabled mobile consumers to remain connected to
growing numbers of voice and data networks. As these cost-effective solutions
have emerged, they have often seen rapid adoption. The benefits of communication
technologies have been validated by the growth of numerous technology markets,
including: Local area networking (LAN) for data and content transfer, and
Internet access; Cellular and cordless handsets; Bluetooth connectivity of
devices within the personal area network; GPS functionality in a variety of
mobile consumer devices; and other markets, including broadcast, satellite
communications and personal area networking markets.
The
stock's price gained 15.5% over the past 3 months (vs. the Industry's
6.8%); 50.5% over the past 6 months (vs. the Industry's 38.7 %); and
124.6% over the past 12 months (vs. the Industry's 89.2%). The Company
is classified as a mid-cap growth company (with a market cap of $2.80B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1998. The Company's principal
executive offices are located Santa Clara, California. The Company
has
1,302 employees.
Sector: Technology;
Industry: Semiconductors
Ticker: ATHR;
Exch:
NASD;
04/30/10
Closing Price:
$38.74
STOCK GRADE (ASG): 45.90 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
11.70% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
11.01% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
14.83% |
|
. . . |
EPS: |
138.74% |
|
. . . |
Price: |
125.55% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
36.22 |
|
. . . |
Earnings/Share: |
3.59 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 04/30/2010: |
$38.84 |
COMMENT: The stock's pick price (of $38.84) is under the 13-day EMA and
over 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $40.66)
and higher than the 50-day EMA (of $38.74) by -0.05% and 0.003% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
04/30/2010: |
$40.66 |
| Price
/ Share (50-day EMA) |
. . . |
04/30/2010: |
$38.74 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
|
May
2010 Stock Picks |
|
Stock Name |
SYM |
Exch. |
Sector |
Industry |
Date Picked |
Pick Price
(per share) |
ASG |
|
Limited Brands Inc. |
LTD |
NYSE |
Services
|
Retail-Apparel |
05/07/10 |
$24.93 |
45.14
(GOOD) |
|
Citrix Systems, Inc. |
CTXS |
NASD |
Technology
|
Software & Programming |
05/14/10 |
$46.51 |
48.20
(GOOD) |
|
Dolby Laboratories, Inc. |
DLB |
NYSE |
Services
|
Motion Pictures |
05/21/10 |
$61.96 |
48.96
(GOOD) |
Limited Brands Inc. (NYSE: LTD) is
a specialty retailer of women’s intimate apparel, beauty and personal care
products and accessories under various trade names. The Company sell its
merchandise through retail stores in the United States and Canada, which are
primarily mall-based, through e-commerce and catalogue direct response channels.
The Company
conducts its business in two primary segments: Victoria’s Secret and Bath & Body
Works. The Company's
products are available in over 3,000 specialty stores nationwide, through the
Victoria's Secret Catalogue and online at www.VictoriasSecret.com,
www.BathandBodyWorks.com, www.HenriBendel.com and www.LaSenza.com.
The Victoria’s Secret segment sells women’s intimate and other apparel, personal
care and beauty products and accessories marketed under the Victoria’s Secret
and La Senza brand names. Victoria’s Secret merchandise is sold through retail
stores, its e-commerce site, www.VictoriasSecret.com, and catalogue. Through its
e-commerce site and catalogue, certain of Victoria’s Secret’s merchandise may be
purchased worldwide. The Victoria’s Secret segment had net sales of $5.607
billion in 2007 and operated 1,020 stores in the United States and 312 stores in
Canada. The Bath & Body Works segment sells personal care, beauty and home
fragrance products marketed under the Bath & Body Works, C.O. Bigelow and White
Barn Candle Company brand names in addition to third-party brands. Bath & Body
Works merchandise is sold through retail stores, its e-commerce site,
www.bathandbodyworks.com, and catalogue. The Bath & Body Works segment had net
sales of $2.494 billion for 2007 and operated 1,592 stores in the United States.
The
stock's price gained 21.8% over the past 3 months (vs. the Industry's
52.5%); 37.1% over the past 6 months (vs. the Industry's 49.5 %); and
107.8% over the past 12 months (vs. the Industry's 215.8%). The Company is classified as a mid-cap
value company (with a market cap of $8.06B)
that is rated to outperform the market over the next six months with a Risk
Level of 3 (Average). The Company was founded in 1963. The Company's principal
executive offices are located Columbus, Ohio. The Company
has
17,100 employees.
Sector: Services;
Industry: Retail-Apparel;
Ticker: LTD;
Exch:
NYSE;
05/07/10
Closing Price:
$24.93
STOCK GRADE (ASG): 45.14 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 3
(Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
22.09% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
5.19% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
-4.54% |
|
. . . |
EPS: |
109.86% |
|
. . . |
Price: |
107.75% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
18.20 |
|
. . . |
Earnings/Share: |
1.37 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 05/07/2010: |
$24.93 |
COMMENT: The stock's pick price (of $24.93) is under the 13-day EMA and
50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $26.65)
and the 50-day EMA (of $25.43) by -6.46% and -1.97% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
05/07/2010: |
$26.65 |
| Price
/ Share (50-day EMA) |
. . . |
05/07/2010: |
$25.43 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Citrix Systems, Inc. (NASD: CTXS) design,
develop, market, sell and support multiple products in an IT market category
called Application Delivery Infrastructure. These products include solutions for
application, server and desktop virtualization, Web application optimization,
application performance monitoring, branch office application delivery and wide
area network, or WAN, optimization, secure sockets layers/virtual private
network, or SSL/VPN, gateways, and Internet Protocol, or IP, telephony.
In many cases, IT organizations have not taken a holistic, architectural
approach to application delivery. Instead they have taken an incremental
approach creating IT systems for delivering applications that are too static,
too complex, and costly to maintain. With slow-growing technology budgets and
fast-changing business needs the strategic, architectural approach to
application, server and desktop delivery that the Company offers has the capacity to
enable its customers to achieve the needed business change. The Company package and
market complete application, server, desktop virtualization solutions and
related services as Citrix Delivery Center. Internally,
the Company
organize its products into four principal groupings: Delivery Systems,
Virtualization and Management Systems, Online Services and Technical Services.
The
stock's price gained 7.8% over the past 3 months (vs. the Industry's
18.0%); 18.0% over the past 6 months (vs. the Industry's 19.0 %); and
70.4% over the past 12 months (vs. the Industry's 194.6%). The Company is classified as a mid-cap
growth company (with a market cap of $8.64B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1989. The Company's principal
executive offices are located Fort Lauderdale Florida. The Company
has
4,816 employees.
Sector: Technology; Industry:
Software & Programming;
Ticker: CTXS;
Exch:
NASD;
05/14/10
Closing Price:
$46.51
STOCK GRADE (ASG): 48.20 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
10.83% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
13.95% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
1.94% |
|
. . . |
EPS: |
8.13% |
|
. . . |
Price: |
70.37% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
37.51 |
|
. . . |
Earnings/Share: |
1.24 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 05/14/2010: |
$46.51 |
COMMENT: The stock's pick price (of $46.51) is under the 13-day EMA and
50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $46.91)
and the 50-day EMA (of $46.73) by -0.86% and -0.47% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
05/14/2010: |
$46.91 |
| Price
/ Share (50-day EMA) |
. . . |
05/14/2010: |
$46.73 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
Dolby Laboratories, Inc. (NYSE: DLB) develops
and delivers products and technologies that improve the entertainment
experience. Dolby technologies are used in virtually all DVD players and
personal computer DVD playback software, increasingly in digital televisions and
portable electronic devices, and also in a wide array of consumer electronic
products such as gaming systems and audio/video receivers. Dolby cinema products
are used in movie theatres around the world. Dolby broadcast products distribute
high-quality audio around the world.
The Company deliver technologies, products and services at each critical
stage of the entertainment chain—content creation, content distribution and
content playback.
The Company work closely
with content creators, including filmmakers, television producers, music
producers, and video-game designers to incorporate Dolby technologies in
entertainment content.
The Company generate
revenue by licensing its technologies to manufacturers of consumer electronics
products and independent software vendors, and selling its professional products
and related services to entertainment content creators, producers, and
distributors.
The
stock's price gained 15.8% over the past 3 months (vs. the Industry's
6.6%); 43.2% over the past 6 months (vs. the Industry's 57.7 %); and
61.0% over the past 12 months (vs. the Industry's 134.4%). The Company is classified as a mid-cap
growth company (with a market cap of $7.03B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1965. The Company's principal
executive offices are located San Francisco, California. The
Company
has
1,135 employees.
Sector: Services;
Industry: Motion Pictures;
Ticker: DLB;
Exch:
NYSE;
05/21/10
Closing Price:
$61.96
STOCK GRADE (ASG): 48.96 (GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
18.92% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
31.31% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
12.38% |
|
. . . |
EPS: |
21.21% |
|
. . . |
Price: |
61.02% |
|
. . . |
Dividend: |
NA |
| PE & EPS (Trailing 12 Mo.) |
. . . |
Price/Earnings: |
28.67 |
|
. . . |
Earnings/Share: |
2.16 |
|
Price / Share (Pick Date, Closing Price) |
. . . |
Pick Date 05/21/2010: |
$61.96 |
COMMENT: The stock's pick price (of $61.96) is under the 13-day EMA and
over the 50-day EMA price range; i.e.,
lower than
the 13-day EMA price
(of $63.90)
and higher than the 50-day EMA (of $61.26) by -3.04% and 1.14% respectively. This suggests that the pick price
IS presently timely AND advantageous buy
price for the stock. (Note: A stock's EMA price changes with
time. SEE also: ACE'S report
ACE'S "Timely"
& "Untimely" Stocks - How to Use and How They Perform" ).
|
. . . |
|
|
| Price
/ Share (13-day EMA) |
. . . |
05/21/2010: |
$63.90 |
| Price
/ Share (50-day EMA) |
. . . |
05/21/2010: |
$61.26 |
| Price
/ Share (13-day EMA) |
. . . |
|
Current:
|
| Price
/ Share (50-day EMA) |
. . . |
|
Current: |
| Price
/ Share (Current) |
. . . |
Current Price |
Quote |
| Price
/ Share (Historical) |
. . . |
Historical Price |
Quote
|
^Top page
|
June
2010 Stock Picks |
|
Stock Name |
SYM |
Exch. |
Sector |
Industry |
Date Picked |
Pick Price
(per share) |
ASG |
|
Universal Health Services, Inc. |
UHS |
NYSE |
Healthcare
|
Healthcare Facilities |
06/04/10 |
$41.57 |
51.26
(VERY GOOD) |
|
Hershey Foods Corp. |
HSY |
NYSE |
Consumer/Non-Cyclical
|
Food Processing |
06/25/10 |
$48.38 |
53.55
(VERY GOOD) |
United Health Services, Inc. (NYSE: UHS) owns
and operates acute care hospitals, behavioral health centers, surgical
hospitals, ambulatory surgery centers and radiation oncology centers.
Services provided by the Company's hospitals include general and
specialty surgery, internal medicine, obstetrics, emergency room care,
radiology, oncology, diagnostic care, coronary care, pediatric services,
pharmacy services and behavioral health services.
As of February 25, 2010, the Company owned and/or operated or had under
construction, 25 acute care hospitals and 102 behavioral health centers located
in 32 states, Washington, D.C. and Puerto Rico. As part of
the Company's
ambulatory treatment centers division, the Company manage and/or own
outright or in partnerships with physicians, 7 surgical hospitals and surgery
and radiation oncology centers located in 5 states and Puerto Rico.
The Company provide capital resources as well as a variety of management
services to its facilities, including central purchasing, information services,
finance and control systems, facilities planning, physician recruitment
services, administrative personnel management, marketing and public relations.
Net revenues from the Company's acute care hospitals, surgical hospitals,
surgery centers and radiation oncology centers accounted for 74% of our
consolidated net revenues in each of 2009, 2008 and 2007. Net revenues from the
Company's behavioral health care facilities accounted for 25% of its
consolidated net revenues during each of 2009, 2008 and 2007.
The
stock's price gained 25.6% over the past 3 months (vs. the Industry's
22.9%); 47.3% over the past 6 months (vs. the Industry's 82.9 %); and
54.3% over the past 12 months (vs. the Industry's 140.0%). The Company is classified as a mid-cap
value company (with a market cap of $4.04B)
that is rated to outperform the market over the next six months with a Risk
Level of 2 (Less than Average). The Company was founded in 1978. The Company's principal
executive offices are located San King of Prussia, Pennsylvania. The Company
has
28,100 employees.
Sector: Healthcare;
Industry: Healthcare Facilities;
Ticker: UHS;
Exch:
NYSE;
06/04/10
Closing Price:
$41.57
STOCK GRADE (ASG): 51.26 (VERY GOOD)
BUSINESS & FINANCIAL SUMMARY;
KEY STATS
(Yahoo)
EXPANDED BUSINESS DESCRIPTION
(Reuters)
STOCK INFO/RESEARCH
(MSN)
COMPETITORS
(CNN Money)
OWNERSHIP
(MSN)
KEY DEVELOPMENTS
(MSN),
RECENT NEWS
(MSN) &
HEADLINES (Yahoo)
HISTORICAL PRICES (Yahoo)
PRICE CHART
(BigCharts)
RISK LEVEL: 2
(Less than Average)
(MSN)
COMPANY'S WEB SITE
|
Management's Effectiveness (Trailing
12 Mo.) |
. . . |
Return on Equity: |
15.48% |
|
Profitability (Trailing
12 Mo.) |
. . . |
Profit Margin: |
5.05% |
|
Stock's Growth Record
(Trailing
12 Mo.) |
. . . |
Revenue: |
3.58% |
|
|
